Dabigatran 150mgCapsule
Cardiac & Anti-Coagulant

Dabigatran 150mg

Dabigatran Etexilate

Direct thrombin inhibitor DOAC for stroke prevention in AF with the advantage of having a specific reversal agent (idarucizumab). Manufactured by Cipla and Natco for export.

Strengths

75mg / 110mg / 150mg

Packing

10 capsules/strip

Origin

India (WHO-GMP)

MOQ

100 units

Export Price

On Request

Availability

In Stock

Request QuotationWhatsApp
Quotation with pricing, availability, and shipping timeline sent within 24 hours.

Product Specifications

Composition
Dabigatran Etexilate Mesilate 75mg / 110mg / 150mg
Dosage Form
Capsule
Available Strengths
75mg / 110mg / 150mg
Packing
10 capsules/strip
Route of Administration
Oral, with or without food, swallow whole
Dosage
AF: 150mg BID (110mg BID if age >=80 or with P-gp inhibitors); VTE prophylaxis: 220mg once daily
Indications
Stroke prevention in non-valvular AF, DVT/PE treatment, VTE prophylaxis after hip/knee replacement
Country of Origin
India (WHO-GMP Certified)
Storage
Store below 30°C, keep in original packaging, protect from moisture
Shelf Life
36 months
Side Effects
Bleeding, dyspepsia, abdominal pain, gastritis, nausea, diarrhea
Precautions
Idarucizumab available as reversal agent; do not open capsules; dose adjustment for renal function; avoid with strong P-gp inhibitors; swallow whole with water

Disclaimer: This information is intended for healthcare professionals and international pharmaceutical buyers only. Product availability, registration status, and approved indications may vary by country. All products are supplied with Certificate of Analysis (CoA), commercial invoice, and packing list. Rx products require valid prescription in the destination country.

Related Products

Metoprolol Succinate 50mgTablet

Metoprolol Succinate 50mg

Metoprolol Succinate

Cardioselective beta-1 adrenoceptor blocker in extended-release formulation that reduces heart rate, blood pressure, and myocardial oxygen demand with once-daily dosing for hypertension, stable angina, and heart failure with reduced ejection fraction. Manufactured to USP standards by Sun Pharma and Cipla and exported globally as a key cardiovascular agent in hypertension, post-MI, and heart failure management protocols.

25mg / 50mg / 100mg
Losartan 50mgTablet

Losartan 50mg

Losartan Potassium

Selective AT1 angiotensin II receptor blocker (ARB) that reduces blood pressure, protects renal function in diabetic nephropathy, and decreases cardiovascular events in hypertensive patients with left ventricular hypertrophy, with a tolerability advantage over ACE inhibitors due to the absence of bradykinin-mediated cough. Manufactured by Cipla and Sun Pharma and exported globally as a widely-used first-line antihypertensive and renoprotective agent.

25mg / 50mg / 100mg
Ramipril 5mgTablet

Ramipril 5mg

Ramipril

Long-acting ACE inhibitor with demonstrated cardiovascular risk reduction benefits across hypertension, post-MI left ventricular dysfunction, chronic heart failure, and diabetic nephropathy, supported by landmark HOPE and REIN trial data. Available in four strengths from Sanofi and Cipla for stepwise titration, exported globally as a cornerstone RAAS agent in both primary and secondary cardiovascular prevention protocols.

1.25mg / 2.5mg / 5mg / 10mg

Need bulk pricing for Dabigatran 150mg?

Send us your quantity requirements and destination country for a custom quotation.

Get Bulk Quote